Exhibit 10.12 FIRST AMENDMENT TO LEASE AGREEMENT THIS FIRST AMENDMENT TO LEASE AGREEMENT ("FIRST AMENDMENT") is made and entered into this 22nd day of July, 2005, by and between NOBLEGENE DEVELOPMENT, LLC, a Tennessee limited liability company...Lease Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc.
Exhibit 10.18 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement") made effective as of December 8, 2003 by and between BioMimetic Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Charles E. Hart (the "Executive"). In...Employment Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Tennessee
Exhibit 10.15 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement") made effective as of November 30, 2004 by and between BioMimetic Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Dr. Samuel E. Lynch (the "Executive"). In...Employment Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Tennessee
Exhibit 10.16 AMENDMENT TO EMPLOYMENT AGREEMENT This AMENDMENT TO EMPLOYMENT AGREEMENT ("Amendment") made effective as of December 1, 2004 by and between BioMimetic Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Dr. Samuel E. Lynch...Employment Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc.
Exhibit 10.9 MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (this "Agreement") dated as of this 9th day of December, 2003 (the "Effective Date") is entered into by and between Luitpold Pharmaceuticals, Inc., a New York...Manufacturing and Supply Agreement • May 9th, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
Common StockUnderwriting Agreement • April 3rd, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Exhibit 10.27 INDEMNIFICATION AGREEMENT This INDEMNIFICATION AGREEMENT (this "Agreement") is made and entered into this ____ day of _____________, 2005 (the "Effective Date") by and between BioMimetics Therapeutics, Inc., a Delaware corporation (the...Indemnification Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Delaware
EXHIBIT 10.14 BIOMIMETIC THERAPEUTICS, INC. 2005 EMPLOYEE STOCK PURCHASE PLAN TABLE OF CONTENTSBiomimetic Therapeutics, Inc. • February 10th, 2006
Exhibit 10.20 [BIOMIMETIC PHARMACEUTICALS LOGO] EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement") made effective as of September 1ST, 2002 by and between BioMimetic Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and James...Employment Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Tennessee
RECITALSPatent Purchase Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Delaware
Exhibit 10.25 AMENDMENT NO. 1 TO MANUFACTURE AND SUPPLY AGREEMENT This Amendment No. 1 is made to the Manufacture and Supply Agreement made December 9, 2003, ("the Agreement") by and between Luitpold Pharmaceuticals, Inc., a New York corporation...Manufacture and Supply Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc.
ARTICLE 1Lease Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Tennessee
EXCLUSIVE PATENT LICENSE AGREEMENT BETWEEN BIOMIMETIC PHARMACEUTICALS, INC. AND ZYMOGENETICS, INC.Exclusive Patent License Agreement • May 10th, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Washington
Exhibit 10.22 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement") made effective as of May 31, 2005 by and between BioMimetic Therapeutics, Inc., a Delaware corporation (the "Company"), and Earl Douglas (the "Executive"). In consideration of...Employment Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Tennessee
AGREEMENT AND PLAN OF MERGER by and among BIOMIMETIC THERAPEUTICS, INC., WRIGHT MEDICAL GROUP, INC., ACHILLES MERGER SUBSIDIARY, INC. AND ACHILLES ACQUISITION SUBSIDIARY, LLC Dated as of November 19, 2012Agreement and Plan of Merger • November 19th, 2012 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
AGREEMENT AND PLAN OF MERGER (hereinafter called this “Agreement”), dated as of November 19, 2012 by and among BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), Wright Medical Group, Inc., a Delaware corporation (“Parent”), Achilles Merger Subsidiary, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”) and Achilles Acquisition Subsidiary, LLC, a Delaware limited liability company and a direct wholly owned Subsidiary of Parent (“Sister Subsidiary”).
Shares BioMimetic Therapeutics, Inc. Common Stock ($0.001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2007 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), Samuel Lynch (“Selling Stockholder A”) and [____] (the “Other Selling Stockholders” and together with Selling Stockholder A, the “Selling Stockholders”) propose to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of [___] shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”) of which [___] shares will be sold by the Company and [__] shares will be sold by the Selling Stockholders. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto and the respective amounts to be sold by the Selling Stockholders are set forth opposite their names on Schedule II. The Company and the Selling Stockholders are sometimes referred to herein collectively as the “Sellers”. The Company [and the Sel
AMENDMENT TO SECOND AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENTInformation and Registration Rights Agreement • April 3rd, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
Exhibit 10.6 SUPPLY AGREEMENT This Supply Agreement (this "Agreement") dated as of this 2nd day of Aug, 2002 (the "Effective Date") is entered into by and between Orthovita, Inc., a Pennsylvania corporation having a principal place of business at 45...Supply Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Pennsylvania
RECITALSExclusive Sublicense Agreement • May 10th, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
BIOMIMETIC THERAPEUTICS, INC., as Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of [____________, _____] Subordinated Debt SecuritiesIndenture • September 1st, 2009 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS INDENTURE, dated as of [__________, ____] between BioMimetic Therapeutics, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Company”), and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”, which term shall include any successor trustee appointed pursuant to Article 7 of this Indenture).
CONTINGENT VALUE RIGHTS AGREEMENT by and between WRIGHT MEDICAL GROUP, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC Dated as of [ — ]Contingent Value Rights Agreement • November 19th, 2012 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [—] (this “CVR Agreement”), by and between Wright Medical Group, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as trustee (the “Trustee”), in favor of each person who from time to time holds one or more Contingent Value Rights (the “Securities” or “CVRs” and, each individually, a “Security” or a “CVR”) to receive cash payments in the amounts and subject to the terms and conditions set forth herein.
EMPLOYMENT AGREEMENTEmployment Agreement • November 5th, 2009 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
This EMPLOYMENT AGREEMENT (“Agreement”) made effective as of July 17, 2009 by and between BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), and Larry Bullock (the “Executive”).
RETENTION AGREEMENTRetention Agreement • December 24th, 2012 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This RETENTION AGREEMENT (this “Agreement”) is made and entered into as of the 20th day of December, 2012 (the “Effective Date”) by and among BioMimetic Therapeutics, Inc. (the “Company”), Wright Medical Group, Inc., a Delaware corporation (the “Parent”) and Dr. Samuel E. Lynch (the “Executive” and, with the Company and the Parent, the “Parties”).
SECOND EXCLUSIVE PATENT LICENSE AGREEMENT BETWEEN BIOMIMETIC PHARMACEUTICALS, INC. AND ZYMOGENETICS, INC.Second Exclusive Patent License Agreement • May 10th, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Washington
Exhibit 10.17 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT ("Agreement") made effective as of December 18, 2003 by and between BioMimetic Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Larry Bullock (the "Executive"). In...Employment Agreement • February 10th, 2006 • Biomimetic Therapeutics, Inc. • Tennessee
RETENTION AGREEMENTRetention Agreement • December 24th, 2012 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This RETENTION AGREEMENT (this “Agreement”) is made and entered into as of the 20th day of December, 2012 (the “Effective Date”) by and between BioMimetic Therapeutics, Inc. (including its successors, the “Company”) and Larry Bullock (the “Executive” and, with the Company, the “Parties”).
RETENTION AGREEMENTRetention Agreement • December 24th, 2012 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This RETENTION AGREEMENT (this “Agreement”) is made and entered into as of the 19th day of December, 2012 (the “Effective Date”) by and between BioMimetic Therapeutics, Inc. (the “Company”) and Russ Pagano (the “Executive” and, with the Company, the “Parties”).
STANDBY PURCHASE AGREEMENTStandby Purchase Agreement • May 14th, 2009 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
we have agreed to bear all reasonable expenses incurred in connection with the registration and sale of the common stock offered by the selling stockholders.
LEASE AGREEMENTLease Agreement • August 21st, 2007 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
THIS LEASE AGREEMENT (the “Lease”) dated as of the 17th day of August, 2007, to be effective on the date last executed below, under the terms and conditions hereinafter set forth, is made and entered into by and between NOBLEGENE DEVELOPMENT, LLC, a Tennessee limited liability company (the “Landlord”) and BIOMIMETIC THERAPEUTICS, INC., a Delaware corporation (the “Tenant”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 19th, 2012 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
This EMPLOYMENT AGREEMENT (“Agreement”) made effective as of July 17, 2012 by and between BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), and Larry Bullock (the “Executive”).
Exhibit 10.8 RESEARCH, DEVELOPMENT AND MARKETING AGREEMENT This RESEARCH, DEVELOPMENT AND MARKETING AGREEMENT ("AGREEMENT") is made effective as of December 9, 2003 ("Effective Date"), by and between Luitpold Pharmaceuticals, Inc., a New York...Research, Development and Marketing Agreement • May 9th, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • March 12th, 2010 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
This Amended and Restated Manufacturing And Supply Agreement (“Agreement”), effective as of 01 December, 2009 (“Effective Date”), is made by and between Novartis Vaccines and Diagnostics, Inc with its headquarters located at 350 Massachusetts Avenue, Cambridge, MA 02139 USA (“Novartis”), and BioMimetic Therapeutics, Inc., a Delaware corporation with its headquarters located at 389 Nichol Mill Lane, Franklin, Tennessee 37067 (“BMTI”).
SEPARATION AGREEMENT AND FULL RELEASESeparation Agreement and Full Release • November 10th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
This Agreement is made and entered into this the 30th day of September, 2008 by and between BioMimetic Therapeutics, Inc., a Delaware corporation with its principal business address at 389 Nichol Mill Lane, Franklin, TN 37067 (the “Company”), and Charles E. Hart (“Employee”) on the following terms and conditions.
LICENSE AGREEMENTLicense Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This Exclusive License Agreement (this “Agreement”) is entered into on January 4, 2008 (the “Effective Date”) between BioMimetic Therapeutics, Inc. (“BMTI”), a Delaware corporation, and Luitpold Pharmaceuticals, Inc. (“Luitpold”), a New York corporation (each, individually, a “Party” and, collectively, the “Parties”).
AGREEMENT TERMINATING MANUFACTURING AND SUPPLY AGREEMENTAgreement Terminating • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AGREEMENT TERMINATING MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), is entered into as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (f/k/a BioMimetic Pharmaceuticals, Inc.) (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Luitpold”). BMTI and Luitpold are each a “party” and are together, the “parties” to this Agreement.
